MedAdvisor Limited (MDR.AX)
AUD 0.09
(-1.05%)
AUD 0.09
(-1.05%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 792.13 Thousand AUD | 107.01% |
| 2023 | -11.3 Million AUD | 34.83% |
| 2022 | -17.34 Million AUD | -24.35% |
| 2021 | -13.94 Million AUD | -45.53% |
| 2020 | -9.58 Million AUD | -18.31% |
| 2019 | -8.1 Million AUD | -81.88% |
| 2018 | -4.45 Million AUD | -29.86% |
| 2017 | -3.42 Million AUD | -11.69% |
| 2016 | -3.07 Million AUD | -360.45% |
| 2015 | -666.96 Thousand AUD | 94.02% |
| 2014 | -11.14 Million AUD | -197.41% |
| 2013 | -3.74 Million AUD | -277.19% |
| 2012 | -993.41 Thousand AUD | -1314.53% |
| 2011 | -70.22 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 FY | 792.13 Thousand AUD | 107.01% |
| 2024 Q4 | -6.07 Million AUD | 0.0% |
| 2024 Q2 | 6.87 Million AUD | 0.0% |
| 2023 Q2 | 4.59 Million AUD | 0.0% |
| 2023 FY | -11.3 Million AUD | 34.83% |
| 2023 Q4 | -15.9 Million AUD | 0.0% |
| 2022 FY | -17.34 Million AUD | -24.35% |
| 2022 Q2 | -7.52 Million AUD | 0.0% |
| 2022 Q4 | -9.82 Million AUD | 0.0% |
| 2021 FY | -13.94 Million AUD | -45.53% |
| 2021 Q4 | -6.18 Million AUD | 0.0% |
| 2021 Q2 | -7.76 Million AUD | 0.0% |
| 2020 FY | -9.58 Million AUD | -18.31% |
| 2020 Q4 | -4.25 Million AUD | 0.0% |
| 2020 Q2 | -5.25 Million AUD | 0.0% |
| 2019 Q2 | -4.5 Million AUD | 0.0% |
| 2019 FY | -8.1 Million AUD | -81.88% |
| 2019 Q4 | -3.59 Million AUD | 0.0% |
| 2018 Q2 | -2.26 Million AUD | 0.0% |
| 2018 FY | -4.45 Million AUD | -29.86% |
| 2018 Q4 | -2.18 Million AUD | 0.0% |
| 2017 Q2 | -2.04 Million AUD | 0.0% |
| 2017 FY | -3.42 Million AUD | -11.69% |
| 2017 Q4 | -1.38 Million AUD | 0.0% |
| 2016 FY | -3.07 Million AUD | -360.45% |
| 2016 Q2 | -1.1 Million AUD | 0.0% |
| 2016 Q4 | -1.96 Million AUD | 0.0% |
| 2015 FY | -666.96 Thousand AUD | 94.02% |
| 2015 Q1 | -2.78 Million AUD | 0.0% |
| 2015 Q3 | -166.74 Thousand AUD | 42.61% |
| 2015 Q4 | -255.57 Thousand AUD | -53.28% |
| 2015 Q2 | -290.55 Thousand AUD | 89.57% |
| 2014 Q3 | -2.78 Million AUD | 0.0% |
| 2014 FY | -11.14 Million AUD | -197.41% |
| 2014 Q4 | -2.78 Million AUD | 0.0% |
| 2014 Q2 | -2.78 Million AUD | -197.41% |
| 2014 Q1 | -936.75 Thousand AUD | 0.0% |
| 2013 Q3 | -936.75 Thousand AUD | 0.0% |
| 2013 Q4 | -936.75 Thousand AUD | 0.0% |
| 2013 Q2 | -936.75 Thousand AUD | -277.19% |
| 2013 Q1 | -248.35 Thousand AUD | 0.0% |
| 2013 FY | -3.74 Million AUD | -277.19% |
| 2012 FY | -993.41 Thousand AUD | -1314.53% |
| 2012 Q1 | -17.55 Thousand AUD | 0.0% |
| 2012 Q2 | -248.35 Thousand AUD | -1314.53% |
| 2012 Q3 | -248.35 Thousand AUD | 0.0% |
| 2012 Q4 | -248.35 Thousand AUD | 0.0% |
| 2011 Q1 | - AUD | 0.0% |
| 2011 FY | -70.22 Thousand AUD | 0.0% |
| 2011 Q4 | -17.55 Thousand AUD | 0.0% |
| 2011 Q2 | -17.55 Thousand AUD | 0.0% |
| 2011 Q3 | -17.55 Thousand AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 Q2 | - AUD | 0.0% |
| 2010 Q3 | - AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alcidion Group Limited | -8.41 Million AUD | 109.411% |
| Artrya Limited | -14 Million AUD | 105.658% |
| Beamtree Holdings Limited | -5.1 Million AUD | 115.514% |
| Cogstate Limited | 8.31 Million AUD | 90.475% |
| Careteq Limited | -2.66 Million AUD | 129.722% |
| Doctor Care Anywhere Group PLC | -10.04 Million AUD | 107.883% |
| Emyria Limited | -11.45 Million AUD | 106.915% |
| Global Health Limited | -1.31 Million AUD | 160.371% |
| HITIQ Limited | -3.2 Million AUD | 124.718% |
| Intelicare Holdings Limited | -2.25 Million AUD | 135.061% |
| ImExHS Limited | -4.19 Million AUD | 118.895% |
| Mach7 Technologies Limited | -7.97 Million AUD | 109.939% |
| Oakridge International Limited | -761.24 Thousand AUD | 204.057% |
| Opyl Limited | -3.13 Million AUD | 125.305% |
| PainChek Limited | -8.3 Million AUD | 109.535% |
| Pro Medicus Limited | 82.79 Million AUD | 99.043% |
| Resonance Health Limited | 169.3 Thousand AUD | -367.879% |
| Singular Health Group Ltd | -4.92 Million AUD | 116.085% |
| Total Brain Limited | -14.78 Million AUD | 105.359% |